Monoclonal antibodies against IgE-associated determinants, hybrid cell lines producing these antibodies, and use therefore
AssigneeG. D. Searle & Co.
InventorsBonita J. Rup, Larry E. Kahn
Life of this patent
Estimating the term…
Abstract
The present invention is directed to monoclonal antibodies and hybridomas which produce them, which react with IgE when it is unbound and thereby inhibit IgE binding to mast cells, and react with IgE when it is bound to the B-cell FcE receptor, but do not react with IgE when it is bound to the mast cell FcE receptor.
Claims2
The monoclonal antibody produced by hybridoma cell line ATCC HB 9436 which specifically binds to IgE and inhibits binding of the IgE to a mast cell FcE receptor and which does not bind to IgE when IgE is bound to a mast cell FcE receptor, but does bind to IgE when IgE is bound to a B-cell FcE receptor.
The hybridoma which is deposited at the American Type Culture Collection under accession number ATCC HB 9436.
Dependencies are inferred from the claim text.